Implementing a national diabetes prevention programme in England: lessons learned.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
23 Dec 2019
Historique:
received: 17 06 2019
accepted: 04 12 2019
entrez: 25 12 2019
pubmed: 25 12 2019
medline: 28 3 2020
Statut: epublish

Résumé

Type 2 diabetes mellitus is preventable through lifestyle intervention. Diabetes prevention programmes (DPPs) aim to deliver prevention-based behaviour change interventions to reduce incidence. Such programmes vary from usual primary care in terms of where, how, and by whom they are delivered. Implementation is therefore likely to face new commissioning, incentive and delivery challenges. We report on the implementation of a national DPP in NHS England, and identify lessons learned in addressing the implementation challenges. In 2017/18, we conducted 20 semi-structured telephone interviews covering 16 sampled case sites with the designated lead(s) responsible for local implementation of the programme. Interviews explored the process of implementation, including organisation of the programme, expectations and attitudes to the programme, funding, target populations and referral and clinical pathways. We drew on constant comparative methods to analyse the data and generate over-arching themes. We complemented our qualitative data with a survey focused on variation in the financial incentives used across sites to ensure usual primary care services recruited patients to new providers. We identified five over-arching areas of learning for implementing this large-scale programme: 1) managing new providers; 2) promoting awareness of services; 3) recruiting patients; 4) incentive payments; and 5) mechanisms for sharing learning. In general, tensions appeared to be caused by a lack of clear roles/responsibilities between hierarchical actors, and lack of communication. Both local sites and the national NHS coordination team gained experience through learning by doing. Initial tensions with roles and expectations have been worked out during implementation. Implementing a national disease prevention programme is a major task, and one that will be increasingly faced by health systems globally as they aim to adjust to demand pressures. We provide practical learning opportunities for the wider uptake and sustainability of prevention programmes. Future implementers might wish to define clear responsibilities for each actor prior to implementation, ensure early engagement with new providers, offer mechanisms/forums for sharing learning, generate evidence and provide advice on incentive payments, and prioritise public and professional awareness of the programme.

Sections du résumé

BACKGROUND BACKGROUND
Type 2 diabetes mellitus is preventable through lifestyle intervention. Diabetes prevention programmes (DPPs) aim to deliver prevention-based behaviour change interventions to reduce incidence. Such programmes vary from usual primary care in terms of where, how, and by whom they are delivered. Implementation is therefore likely to face new commissioning, incentive and delivery challenges. We report on the implementation of a national DPP in NHS England, and identify lessons learned in addressing the implementation challenges.
METHODS METHODS
In 2017/18, we conducted 20 semi-structured telephone interviews covering 16 sampled case sites with the designated lead(s) responsible for local implementation of the programme. Interviews explored the process of implementation, including organisation of the programme, expectations and attitudes to the programme, funding, target populations and referral and clinical pathways. We drew on constant comparative methods to analyse the data and generate over-arching themes. We complemented our qualitative data with a survey focused on variation in the financial incentives used across sites to ensure usual primary care services recruited patients to new providers.
RESULTS RESULTS
We identified five over-arching areas of learning for implementing this large-scale programme: 1) managing new providers; 2) promoting awareness of services; 3) recruiting patients; 4) incentive payments; and 5) mechanisms for sharing learning. In general, tensions appeared to be caused by a lack of clear roles/responsibilities between hierarchical actors, and lack of communication. Both local sites and the national NHS coordination team gained experience through learning by doing. Initial tensions with roles and expectations have been worked out during implementation.
CONCLUSIONS CONCLUSIONS
Implementing a national disease prevention programme is a major task, and one that will be increasingly faced by health systems globally as they aim to adjust to demand pressures. We provide practical learning opportunities for the wider uptake and sustainability of prevention programmes. Future implementers might wish to define clear responsibilities for each actor prior to implementation, ensure early engagement with new providers, offer mechanisms/forums for sharing learning, generate evidence and provide advice on incentive payments, and prioritise public and professional awareness of the programme.

Identifiants

pubmed: 31870371
doi: 10.1186/s12913-019-4809-3
pii: 10.1186/s12913-019-4809-3
pmc: PMC6929377
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

991

Subventions

Organisme : Department of Health
ID : 16/48/07
Pays : United Kingdom
Organisme : Department of Health
ID : HS&DR/16/48/07
Pays : United Kingdom
Organisme : Health Services and Delivery Research Programme
ID : 16/48/07

Références

BMC Health Serv Res. 2019 Apr 15;19(1):228
pubmed: 30987616
BMJ Open. 2018 Feb 21;8(2):e019467
pubmed: 29467134
Diabetes Metab J. 2017 Jun;41(3):160-167
pubmed: 28537055
J Health Serv Res Policy. 2018 Apr;23(2):107-115
pubmed: 29475369
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
Diabet Med. 2012 Jul;29(7):855-62
pubmed: 22537247
Diabetes Care. 2014 Apr;37(4):934-42
pubmed: 24319121
Implement Sci. 2015 Dec 15;10:172
pubmed: 26670418
Implement Sci. 2013 Oct 02;8:117
pubmed: 24088228
Diabetologia. 2013 Feb;56(2):284-93
pubmed: 23093136
Diabetes Care. 2002 Dec;25(12):2165-71
pubmed: 12453955
Int J Circumpolar Health. 2007 Apr;66(2):101-12
pubmed: 17515250
Implement Sci. 2017 Jul 26;12(1):94
pubmed: 28747191
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetologia. 1999 Jul;42(7):793-801
pubmed: 10440120
BMJ Open. 2019 Apr 14;9(4):e024156
pubmed: 30987985
Transl Behav Med. 2011 Jun;1(2):270-282
pubmed: 21765880
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
BMC Health Serv Res. 2019 May 22;19(1):321
pubmed: 31113426
Diabetes Care. 1999 Apr;22(4):623-34
pubmed: 10189543
Int J Care Coord. 2018 Jun;21(1-2):50-54
pubmed: 29881630
J Health Serv Res Policy. 2018 Oct;23(4):243-251
pubmed: 29984592

Auteurs

Jonathan Stokes (J)

Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK. jonathan.m.stokes@manchester.ac.uk.

Judith Gellatly (J)

Division of Nursing, University of Manchester, Manchester, UK.

Peter Bower (P)

Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.

Rachel Meacock (R)

Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.

Sarah Cotterill (S)

Centre for Biostatistics, University of Manchester, Manchester, UK.

Matt Sutton (M)

Centre for Primary Care and Health Services Research, University of Manchester, Manchester, UK.

Paul Wilson (P)

Alliance Manchester Business School, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH